Evidence map›Paper›PMID 21517116›Full record

ArticleACS chemical biology2011

Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin.

Ian M Gut, Steven R Blanke, Wilfred A van der Donk

Open access · bronzeAbstract read
In one paragraph

Article in ACS chemical biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 106 citations in OpenAlex.

  1. Probiotics and Fermented Foods in Human Nutrition.Molecules (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Fast-growingbioRxiv : the preprint server for biology · 2025
    Article
  4. Review
  5. Strategies for effective high pressure germination or inactivation ofApplied and environmental microbiology · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Inhibitory activities of propolis, nisin, melittin and essential oil compounds onThe journal of venomous animals and toxins including tropical diseases · 2022
    Article
  12. Review
  13. Genomic and proteomic comparisons of bacteriocins in probiotic speciesBiotechnology reports (Amsterdam, Netherlands) · 2021
    Article
  14. Teicoplanin Suppresses VegetativeAntibiotics (Basel, Switzerland) · 2021
    Article
  15. Opportunities for Nanomedicine inAntibiotics (Basel, Switzerland) · 2021
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ian M GutDepartment of Microbiology, University of Illinois, Urbana, Illinois 61801, United States.
Steven R Blanke
Wilfred A van der Donk
Howard Hughes Medical Institute · US

Funding

WRCE Nonhuman Primate CoreU54AI057156 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WALKER, DAVID H · 2003 to 2013
$102.6M
Training Program in Chemistry-Interface with BiologyT32GM070421 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI HERGENROTHER, PAUL · 2005 to 2019
$5.4M
Howard Hughes Medical InstituteNIAID NIH HHS U54 AI057156NIAID NIH HHS U54-AI057156NIGMS NIH HHS 5 T32GM070421NIGMS NIH HHS T32 GM070421
6 · The paper itself

Abstract

The lantibiotic nisin inhibits growth of vegetative Gram-positive bacteria by binding to lipid II, which disrupts cell wall biosynthesis and facilitates pore formation. Nisin also inhibits the outgrowth of bacterial spores, including spores of Bacillus anthracis, whose structural and biochemical properties are fundamentally different from those of vegetative bacteria. The molecular basis of nisin inhibition of spore outgrowth had not been identified, as previous studies suggested that inhibition of spore outgrowth involved either covalent binding to a spore target or loss of membrane integrity; disruption of cell wall biosynthesis via binding to lipid II had not been investigated. To provide insights into the latter possibility, the effects of nisin were compared with those of vancomycin, another lipid II binding antibiotic that inhibits cell wall biosynthesis but does not form pores. Nisin and vancomycin both inhibited the replication of vegetative cells, but only nisin inhibited the transition from a germinated spore to a vegetative cell. Moreover, vancomycin prevented nisin's activity in competition studies, suggesting that the nisin-lipid II interaction is important for inhibition of spore outgrowth. In experiments with fluorescently labeled nisin, no evidence was found for a covalent mechanism for inhibition of spore outgrowth. Interestingly, mutants in the hinge region (N20P/M21P and M21P/K22P) that still bind lipid II but cannot form pores had potent antimicrobial activity against vegetative B. anthracis cells but did not inhibit spore outgrowth. Therefore, pore formation is essential for the latter activity but not the former. Collectively, these studies suggest that nisin utilizes lipid II as the germinated spore target during outgrowth inhibition and that nisin-mediated membrane disruption is essential to inhibit spore development into vegetative cells.

Indexed as

Anti-Bacterial AgentsBacillus anthracisBoron CompoundsCell MembraneCell WallFluorescent DyesMembrane PotentialsMutationNisinSpores, BacterialUridine Diphosphate N-Acetylmuramic AcidVancomycin4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneAnti-Bacterial AgentsBoron CompoundsFluorescent Dyesmuramyl-NAc-(pentapeptide)pyrophosphoryl-undecaprenolNisinUridine Diphosphate N-Acetylmuramic AcidVancomycin

Identifiers

PMID21517116
PMCPMC3178273
OpenAlexW2009097399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.